tiprankstipranks
Trending News
More News >
Arkema (FR:AKE)
:AKE
Advertisement

Arkema (AKE) AI Stock Analysis

Compare
30 Followers

Top Page

FR:AKE

Arkema

(AKE)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - 4o)
Rating:70Outperform
Price Target:
€68.00
▲(29.52% Upside)
Arkema's overall stock score reflects a stable financial position with challenges in revenue and cash flow, balanced by attractive dividend yield and moderate technical indicators. The lack of earnings call and corporate events data limits further insights.
Positive Factors
Negative Factors

Arkema (AKE) vs. iShares MSCI France ETF (EWQ)

Arkema Business Overview & Revenue Model

Company DescriptionArkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates through Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates segments. It provides adhesive solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets. The company also offers advanced materials consisting of specialty polyamides and polyvinylidene fluoride; and performance additives, such as specialty surfactants and molecular sieves, organic peroxides, thiochemicals, and hydrogen peroxide for use in automotive and transportation, oil and gas, renewable energies, consumer goods, electronics, construction, coatings, animal nutrition, and water treatment sectors. In addition, it provides coating solutions comprising EU/US acrylics and coating resins; sartomer photocure resins and coatex rheology additives; decorative paints, industrial coatings, and adhesives; and solutions for applications in the paper, superabsorbents, water treatment and oil and gas extraction, and 3D printing and electronics industries. Further, the company offers fluorogases and acrylics; and industrial intermediate chemicals used in construction, refrigeration and air conditioning, automotive, coatings, and water treatment sectors. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France.
How the Company Makes MoneyArkema generates revenue primarily through the sale of its specialty chemicals and materials across various market sectors. The company has a diverse revenue model that includes direct sales to manufacturers and end-users, as well as partnerships with key players in the industries it serves. Significant revenue streams come from its High Performance Materials segment, which produces advanced materials used in high-growth applications like electric vehicles and renewable energy. Additionally, Arkema benefits from strategic collaborations and acquisitions that enhance its product offerings and market reach, contributing positively to its earnings.

Arkema Financial Statement Overview

Summary
Arkema's financial performance shows challenges in revenue growth and profitability margins, with a stable balance sheet but declining cash flow metrics. The company maintains operational efficiency, but needs to address declining revenue and cash flow to ensure long-term financial health.
Income Statement
65
Positive
Arkema's income statement shows a declining trend in revenue and profitability margins over the TTM period. The gross profit margin and net profit margin have decreased compared to previous years, indicating pressure on profitability. Revenue growth has been negative, reflecting challenges in maintaining sales momentum. However, the company maintains a positive EBIT and EBITDA margin, suggesting operational efficiency despite the downturn.
Balance Sheet
72
Positive
The balance sheet reflects a stable financial position with a moderate debt-to-equity ratio, indicating manageable leverage. The return on equity has decreased, suggesting reduced profitability for shareholders. The equity ratio remains healthy, showing a strong capital structure. Overall, the balance sheet suggests financial stability but highlights the need for improved profitability.
Cash Flow
60
Neutral
Cash flow analysis reveals a decline in free cash flow growth, which could impact future investments and debt servicing. The operating cash flow to net income ratio is moderate, indicating adequate cash generation relative to earnings. However, the free cash flow to net income ratio has decreased, pointing to potential liquidity challenges. The company needs to focus on improving cash flow generation to support its financial commitments.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue9.44B9.54B9.51B11.55B9.52B7.88B
Gross Profit1.80B1.94B1.96B2.58B2.14B1.55B
EBITDA1.10B1.31B1.33B1.82B2.27B1.19B
Net Income226.00M354.00M402.00M965.00M1.31B332.00M
Balance Sheet
Total Assets13.92B15.21B14.52B13.51B12.30B10.71B
Cash, Cash Equivalents and Short-Term Investments1.31B2.01B2.04B1.59B2.29B1.63B
Total Debt3.79B4.55B4.28B3.26B2.76B2.80B
Total Liabilities6.47B7.45B7.06B6.17B5.95B5.48B
Stockholders Equity7.23B7.53B7.20B7.30B6.30B5.19B
Cash Flow
Free Cash Flow211.00M353.00M622.00M766.00M152.00M510.00M
Operating Cash Flow1.00B1.12B1.26B1.50B915.00M1.11B
Investing Cash Flow-900.00M-940.00M-1.35B-2.34B473.00M-458.00M
Financing Cash Flow-953.00M-207.00M516.00M168.00M-652.00M-535.00M

Arkema Technical Analysis

Technical Analysis Sentiment
Negative
Last Price52.50
Price Trends
50DMA
56.88
Negative
100DMA
59.45
Negative
200DMA
64.13
Negative
Market Momentum
MACD
-1.58
Negative
RSI
44.32
Neutral
STOCH
80.82
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:AKE, the sentiment is Negative. The current price of 52.5 is below the 20-day moving average (MA) of 52.51, below the 50-day MA of 56.88, and below the 200-day MA of 64.13, indicating a bearish trend. The MACD of -1.58 indicates Negative momentum. The RSI at 44.32 is Neutral, neither overbought nor oversold. The STOCH value of 80.82 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:AKE.

Arkema Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
€1.63B15.311.39%10.55%13.50%
70
Outperform
€3.94B18.123.56%6.86%0.19%-37.62%
66
Neutral
€99.77B29.0813.92%1.91%1.46%12.62%
62
Neutral
€3.59B9.9616.47%9.81%-15.12%-10.10%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
52
Neutral
€1.81B-5.29%6.71%-7.71%-451.19%
50
Neutral
€1.75B-7.36%2.53%-6.91%-222.35%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:AKE
Arkema
52.50
-24.75
-32.04%
FR:AI
Air Liquide
173.04
6.73
4.05%
FR:ERA
Eramet SA
59.60
10.90
22.39%
FR:NK
IMERYS SA
21.62
-6.11
-22.05%
FR:VK
Vallourec
15.29
2.59
20.42%
FR:CBE
Robertet SA Cert.d'Invest. Em.87
697.00
-91.05
-11.55%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 27, 2025